Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy?
Ann Transl Med
.
2013 Jul;1(2):12.
doi: 10.3978/j.issn.2305-5839.2013.01.03.
Authors
Alessio Amatu
1
,
Katia Bencardino
1
,
Andrea Sartore-Bianchi
1
,
Salvatore Siena
1
Affiliation
1
Department of Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy.
PMID:
25332957
PMCID:
PMC4200636
DOI:
10.3978/j.issn.2305-5839.2013.01.03
No abstract available